Caisse de Depot et Placement du Quebec (CDPQ)’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.7M Sell
50,917
-62,851
-55% -$29.3M 0.04% 350
2025
Q4
$51.6M Sell
113,768
-108,494
-49% -$46.8M 0.09% 240
2025
Q3
$87M Buy
222,262
+157,866
+245% +$66M 0.16% 158
2025
Q2
$28.7M Sell
64,396
-60,451
-48% -$27.9M 0.06% 265
2025
Q1
$60.5M Sell
124,847
-16,870
-12% -$7.86M 0.13% 177
2024
Q4
$57.1M Sell
141,717
-230,252
-62% -$107M 0.12% 187
2024
Q3
$173M Sell
371,969
-183,696
-33% -$88.2M 0.34% 72
2024
Q2
$260M Sell
555,665
-299,444
-35% -$130M 0.63% 33
2024
Q1
$357M Buy
855,109
+51,383
+6% +$21.7M 0.86% 19
2023
Q4
$327M Sell
803,726
-12,298
-2% -$4.54M 0.83% 25
2023
Q3
$284M Sell
816,024
-54,052
-6% -$18.9M 0.82% 25
2023
Q2
$306M Sell
870,076
-143,147
-14% -$48.2M 0.81% 24
2023
Q1
$319M Buy
1,013,223
+103,202
+11% +$31M 0.91% 25
2022
Q4
$263M Sell
910,021
-175,199
-16% -$53.4M 0.81% 26
2022
Q3
$314M Sell
1,085,220
-193,874
-15% -$55.8M 0.91% 26
2022
Q2
$360M Buy
1,279,094
+104,486
+9% +$28M 0.99% 28
2022
Q1
$307M Sell
1,174,608
-53,900
-4% -$12.8M 0.72% 36
2021
Q4
$270M Sell
1,228,508
-266,708
-18% -$51.9M 0.58% 48
2021
Q3
$271M Buy
1,495,216
+1,438,039
+2,515% +$281M 0.58% 49
2021
Q2
$11.5M Buy
57,177
+48,476
+557% +$10.1M 0.02% 240
2021
Q1
$1.87M Buy
8,701
+6,925
+390% +$1.52M ﹤0.01% 452
2020
Q4
$420K Sell
1,776
-1,229
-41% -$282K ﹤0.01% 621
2020
Q3
$818K Sell
3,005
-600
-17% -$166K ﹤0.01% 570
2020
Q2
$1.05M Sell
3,605
-38
-1% -$10.3K ﹤0.01% 529
2020
Q1
$867K Sell
3,643
-4,762
-57% -$1.09M ﹤0.01% 574
2019
Q4
$1.84M Buy
8,405
+5,760
+218% +$1.17M ﹤0.01% 475
2019
Q3
$448K Sell
2,645
-660
-20% -$117K ﹤0.01% 775
2019
Q2
$606K Sell
3,305
-2,000
-38% -$350K ﹤0.01% 686
2019
Q1
$976K Sell
5,305
-400
-7% -$73.9K ﹤0.01% 616
2018
Q4
$945K Buy
5,705
+500
+10% +$86.6K ﹤0.01% 609
2018
Q3
$1M Sell
5,205
-200
-4% -$35.6K ﹤0.01% 621
2018
Q2
$919K Buy
5,405
+100
+2% +$15.5K ﹤0.01% 632
2018
Q1
$865K Sell
5,305
-94,600
-95% -$15.5M ﹤0.01% 622
2017
Q4
$15M Buy
99,905
+92,000
+1,164% +$13.6M 0.03% 208
2017
Q3
$1.21M Buy
7,905
+100
+1% +$15.1K ﹤0.01% 577
2017
Q2
$1M Buy
7,805
+200
+3% +$24.1K ﹤0.01% 588
2017
Q1
$833K Buy
7,605
+300
+4% +$26.4K ﹤0.01% 582
2016
Q4
$537K Sell
7,305
-1,200
-14% -$97.6K ﹤0.01% 647
2016
Q3
$742K Sell
8,505
-500
-6% -$47.3K ﹤0.01% 663
2016
Q2
$775K Buy
9,005
+2,000
+29% +$173K ﹤0.01% 712
2016
Q1
$557K Sell
7,005
-97,495
-93% -$8.82M ﹤0.01% 730
2015
Q4
$13.1M Sell
104,500
-3,600
-3% -$435K 0.04% 210
2015
Q3
$11.3M Buy
108,100
+1,000
+0.9% +$128K 0.03% 243
2015
Q2
$13.2M Buy
107,100
+300
+0.3% +$37.8K 0.03% 231
2015
Q1
$12.6M Sell
106,800
-9,900
-8% -$1.19M 0.04% 251
2014
Q4
$13.9M Sell
116,700
-9,200
-7% -$1.04M 0.04% 227
2014
Q3
$14.1M Sell
125,900
-3,300
-3% -$314K 0.04% 240
2014
Q2
$12.2M Sell
129,200
-6,100
-5% -$428K 0.03% 271
2014
Q1
$9.57M Buy
135,300
+3,500
+3% +$277K 0.03% 322
2013
Q4
$9.79M Sell
131,800
-18,000
-12% -$1.25M 0.03% 339
2013
Q3
$11.4M Buy
149,800
+141,600
+1,727% +$11.3M 0.03% 347
2013
Q2
$655K Buy
+8,200
New +$604K ﹤0.01% 760

Other funds holding VRTX

Caisse de Depot et Placement du Quebec (CDPQ)'s VRTX Position: Q1 2026 in Review

Caisse de Depot et Placement du Quebec (CDPQ) reduced its Vertex Pharmaceuticals (VRTX) stake by 55% in Q1 2026, selling an estimated $29.3M and leaving 50,917 shares worth $22.7M. The position accounts for 0.04% of the portfolio, ranked #350.

Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $360M in Q2 2022. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Caisse de Depot et Placement du Quebec (CDPQ) held 50,917 shares of Vertex Pharmaceuticals worth $22.7M as of Q1 2026.
  • Caisse de Depot et Placement du Quebec (CDPQ) sold 62,851 Vertex Pharmaceuticals shares in Q1 2026, an estimated $29.3M.
  • Vertex Pharmaceuticals made up 0.04% of Caisse de Depot et Placement du Quebec (CDPQ)'s portfolio in Q1 2026, its #350 holding.
  • Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Caisse de Depot et Placement du Quebec (CDPQ)'s Vertex Pharmaceuticals position peaked at $360M in Q2 2022.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Caisse de Depot et Placement du Quebec (CDPQ)'s 13F filing for Q1 2026, filed 14 May 2026.